Canada markets closed

Avanos Medical, Inc. (AVNS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
19.58+0.11 (+0.56%)
At close: 04:00PM EDT
19.58 0.00 (0.00%)
After hours: 05:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 898.80M
Enterprise Value 1.04B
Trailing P/E 154.57
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.34
Price/Book (mrq)0.73
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 3-15.57%
S&P500 52-Week Change 326.27%
52 Week High 326.56
52 Week Low 317.24
50-Day Moving Average 319.23
200-Day Moving Average 320.26

Share Statistics

Avg Vol (3 month) 3231.57k
Avg Vol (10 day) 3236.6k
Shares Outstanding 545.9M
Implied Shares Outstanding 646.27M
Float 842.05M
% Held by Insiders 12.86%
% Held by Institutions 198.28%
Shares Short (Apr 30, 2024) 4968.29k
Short Ratio (Apr 30, 2024) 44.92
Short % of Float (Apr 30, 2024) 43.01%
Short % of Shares Outstanding (Apr 30, 2024) 42.11%
Shares Short (prior month Mar 28, 2024) 41.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -9.15%
Operating Margin (ttm)4.51%

Management Effectiveness

Return on Assets (ttm)2.18%
Return on Equity (ttm)-0.13%

Income Statement

Revenue (ttm)680.1M
Revenue Per Share (ttm)14.63
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)N/A
EBITDA 104.7M
Net Income Avi to Common (ttm)-1.6M
Diluted EPS (ttm)-0.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)75.8M
Total Cash Per Share (mrq)1.64
Total Debt (mrq)214.7M
Total Debt/Equity (mrq)17.49%
Current Ratio (mrq)2.28
Book Value Per Share (mrq)26.58

Cash Flow Statement

Operating Cash Flow (ttm)31.2M
Levered Free Cash Flow (ttm)81.04M